GNTI-823

N/A

Report date: 2025/05/15 16:19:08

Base Information

Drug NameGNTI-823
Drug Alias NameGNTI-823
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeInflammationAcute Kidney Injury +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGentiBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesGentiBio Inc
Inactive CompaniesN/A
Active IndicationsIschemic StrokeInflammationAcute Kidney Injury +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A